Enterprise Products
THERAPIVA PRIVATE LIMITED, an Indian company, manufactures and sells a wide range of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates.
Their product portfolio primarily includes the following APIs:
Oncology APIs: Cabazitaxel, Pemetrexed Diacid, Pemetrexed Disodium, Dasatinib, Erdafitinib, Apalutamide, Enzalutamide, Neratinib, Olaparib, Palbociclib, Trametinib, Binimetinib, Ribociclib Succinate, Abemaciclib, Sunitinib Malate, Regorafenib, Lenalidomide, Pomalidomide, Ibrutinib, Acalabrutinib, Ceritinib, Brigatinib, Lorlatinib, Crizotinib, Alectinib, Osimertinib, Afatinib Dimaleate, Dacomitinib, Lapatinib Ditosylate, Everolimus, Sirolimus, Temsirolimus, Venetoclax, Capmatinib Hydrochloride, Tucatinib, Sotorasib, Mobocertinib, Tirbanibulin, Futibatinib, Belumosudil Mesylate, Asciminib, Pirtobrutinib, Zanubrutinib, Repotrectinib.
Non-Oncology APIs: Fingolimod Hydrochloride, Ozanimod Hydrochloride, Eslicarbazepine Acetate, Lacosamide, Vigabatrin, Perampanel, Cenobamate, Rufinamide, Ivacaftor, Tezacaftor, Elexacaftor, Lumacaftor, Voclosporin, Filgotinib, Upadacitinib, Tofacitinib Citrate, Baricitinib, Deucravacitinib, Ruxolitinib Phosphate, Fedratinib, Momelotinib, Tirzepatide, Semaglutide, Liraglutide, Dapagliflozin, Empagliflozin, Canagliflozin, Ertugliflozin, Remogliflozin Etabonate, Luseogliflozin, Tafamidis, Tafamidis Meglumine, Vonoprazan Fumarate, Tenapanor, Lixisenatide, Dulaglutide, Exenatide, Pramlintide Acetate, Setmelanotide Acetate, Tesamorelin Acetate.
The company also provides various pharmaceutical intermediates that support the synthesis of their API portfolio and offers custom synthesis services.